Immunosuppressive treatment facilitates hepatic recompensation in patients with decompensated cirrhosis due to autoimmune hepatitis-a pilot study

被引:0
|
作者
Hofer, Benedikt [1 ,2 ,3 ,4 ]
Burghart, Lukas [5 ]
Treiber, Sonja [1 ]
Halilbasic, Emina [1 ,4 ]
Mandorfer, Mattias [1 ,2 ]
Trauner, Michael [1 ,4 ]
Reiberger, Thomas [1 ,2 ,3 ,4 ]
Staettermayer, Albert Friedrich [1 ,4 ]
机构
[1] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna, Austria
[2] Med Univ Vienna, Div Gastroenterol & Hepatol, Dept Internal Med 3, Vienna Hepat Hemodynam Lab, Vienna, Austria
[3] Med Univ Vienna, Christian Doppler Lab Portal Hypertens & Liver Fi, Vienna, Austria
[4] Vienna Gen Hosp, Rare Liver Dis RALID Ctr, ERN RARE LIVER, Vienna, Austria
[5] Klin Ottakring, Wiener Gesundheitsverbund, Vienna, Austria
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
THU-183-YI
引用
收藏
页码:S341 / S342
页数:2
相关论文
共 50 条
  • [11] Impact of immunosuppressive treatment on hepatic histopathology in autoimmune hepatitis
    Heurgue-Berlot, Alexandra
    Bernard-Chabert, Brigitte
    Louvet, Herve
    Bresson-Hadni, Solange
    Ehrhard, Florent
    Picol, Remi
    Renard, Pascal
    Diebold, Marie-Daniele N.
    Thiefin, Gerard
    HEPATOLOGY, 2013, 58 : 569A - 570A
  • [12] Immunosuppressive treatment in autoimmune decompensated cirrhosis, when to say enough: A retrospective analysis
    Barbero, Manuel
    Burgos, Stefania
    Roca, Ignacio
    Navarro, Lucia
    Cairo, Fernando
    MEDICINE, 2025, 104 (06)
  • [13] Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis
    Ustundag, Gonca
    Kuloglu, Zarife
    Kirsaclioglu, Ceyda Tuna
    Kansu, Aydan
    Erden, Esra
    Girgin, Nurten
    PEDIATRICS INTERNATIONAL, 2008, 50 (05) : 711 - 713
  • [14] ON-TREATMENT SERUM ALBUMIN LEVELS CAN PREDICT RECOMPENSATION IN ENTECAVIR-TREATED HEPATITIS B PATIENTS WITH DECOMPENSATED CIRRHOSIS
    Deng, You
    Wang, Qi
    Zhao, Hong
    Cao, Ying
    Zhang, Shuqian
    Xie, Wen
    HEPATOLOGY, 2022, 76 : S1200 - S1201
  • [15] SERUM N-GLYCANS AS PREDICTIVE BIOMARKERS FOR RECOMPENSATION IN PATIENTS WITH CHRONIC HEPATITIS B AND DECOMPENSATED CIRRHOSIS
    Deng, You
    Wang, Qi
    Zhao, Hong
    Wu, Qian
    Chen, Cuiying
    Chen, Wenya
    Li, Jiashuo
    Li, Mengqi
    Xie, Wen
    HEPATOLOGY, 2024, 80 : S1693 - S1693
  • [16] Lamivudine treatment in patients with severely decompensated cirrhosis due to replicating hepatitis B infection
    Yao, FY
    Bass, NM
    JOURNAL OF HEPATOLOGY, 2000, 33 (02) : 301 - 307
  • [17] Recompensation factors for patients with decompensated cirrhosis: a multicentre retrospective case-control study
    Xu, Xiaomei
    Wang, Haolin
    Zhao, Wenlong
    Wang, Yong
    Wang, Jiayue
    Qin, Bo
    BMJ OPEN, 2021, 11 (06):
  • [18] Lamivudine treatment for decompensated cirrhosis due to hepatitis B: A multicenter longitudinal study.
    Hann, HWL
    Fontana, RJ
    Wright, T
    Baker, A
    Everson, GT
    Schiff, ER
    Riely, C
    Riker-Hopkins, M
    Hamedani, A
    Brown, NA
    GASTROENTEROLOGY, 2000, 118 (04) : A1004 - A1004
  • [19] Autoimmune Hepatitis-related Cirrhosis: Clinical Features and Effectiveness of Immunosuppressive Treatment in Chinese Patients
    Li YanNi
    Ma Huan
    Zhou Lu
    Zhang Jie
    Guo LiPing
    Li ShuQian
    Qian YiQi
    Wang BangMao
    Department of Gastroenterology and Hepatology Tianjin Medical University General Hospital Tianjin Medical University Tianjin China
    Department of Gastroenterology and Hepatology Hebei Medical University Third Hospital Hebei Medical University Shijiazhuang Heibei China
    Department of Preventive Medicine School of Public Health Tianjin Medical University Tianjin China
    中华医学杂志英文版, 2016, 129 (20) : 2434 - 2440
  • [20] Long-term outcomes of patients with autoimmune hepatitis induced cirrhosis after immunosuppressive treatment
    Hatoum, Sara
    Rockey, Don C.
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2024, 36 (06) : 742 - 749